Medicine and Dentistry
Esophagectomy
100%
Esophageal Cancer
98%
Stomach Cancer
55%
Neoplasm
35%
Lymph Node Metastasis
31%
Esophageal Squamous Cell Carcinoma
29%
Recurrent Disease
27%
Surgery
25%
Sentinel Node
23%
Overall Survival
22%
Gastrectomy
20%
Metastatic Carcinoma
17%
Sentinel-Node Mapping
16%
Retroperitoneal Lymph Node Dissection
16%
Lymph Node
14%
Chemoradiotherapy
14%
Clinical Significance
13%
Thoracic Duct
12%
Fibrinogen
12%
Postoperative Complication
12%
Anastomosis Leakage
12%
Prognostic Factor
12%
Endoscopic Surgery
12%
Recurrence Free Survival
10%
Malignant Neoplasm
10%
Neoadjuvant Chemotherapy
9%
Enteric Feeding
8%
Esophagus
8%
Endoscopic Submucosal Dissection
8%
Cisplatin
8%
Carcinoma
7%
Lymphocyte
7%
Squamous Cell Carcinoma
7%
Reflux Esophagitis
7%
Multivariate Analysis
7%
Disease
6%
Diagnosis
6%
C Reactive Protein
6%
Survival Rate
6%
Esophagus Carcinoma
5%
Psoas Muscle
5%
Neutrophil
5%
Hazard Ratio
5%
Laparoscopy
5%
Clinical Feature
5%
Mediastinal Lymph Node
5%
Recurrent Laryngeal Nerve Palsy
5%
Stomach Carcinoma
5%
Prospective Cohort Study
5%
Lung Metastasis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Stomach Cancer
41%
Esophagus Cancer
27%
Chemotherapy
24%
Esophageal Squamous Cell Carcinoma
19%
Neoplasm
15%
Cisplatin
14%
Recurrent Disease
13%
Overall Survival
12%
Chemoradiation Therapy
10%
Lymph Node Metastasis
9%
Fibrinogen
7%
Recurrence Free Survival
6%
Malignant Neoplasm
6%
Anticarcinogen
6%
Prospective Cohort Study
5%
Helicobacter Infection
5%
Lung Metastasis
5%
Keyphrases
Esophageal Cancer
36%
Post-esophagectomy
13%
Esophagectomy
12%
Advanced Gastric Cancer
10%
Radical Esophagectomy
9%
Esophageal Squamous Cell Carcinoma
8%
Cancer Patients
8%
Thoracic Esophageal Cancer
8%
Cisplatin
7%
Early Gastric Cancer
7%
Postoperative Complications
6%
Postoperative Pneumonia
6%
Prognostic Significance
5%
Gastric Cancer
5%
Overall Survival
5%
Non-exposed Endoscopic Wall-inversion Surgery
5%
Reflux Esophagitis
5%
Diagnostic Factor
5%
Endoscopic Classification
5%
Salvage Esophagectomy
5%
Fibrinogen
5%
Gastric Submucosal Tumor
5%
S809
5%
Albumin
5%
Early Postoperative
5%
Psoas muscle Index
5%
Lung Metastasis
5%